CN112402569A - Anti-fatigue health product and preparation method thereof - Google Patents
Anti-fatigue health product and preparation method thereof Download PDFInfo
- Publication number
- CN112402569A CN112402569A CN202011326832.4A CN202011326832A CN112402569A CN 112402569 A CN112402569 A CN 112402569A CN 202011326832 A CN202011326832 A CN 202011326832A CN 112402569 A CN112402569 A CN 112402569A
- Authority
- CN
- China
- Prior art keywords
- parts
- fatigue
- health product
- fatigue health
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 64
- 230000036541 health Effects 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title description 6
- 239000003814 drug Substances 0.000 claims abstract description 39
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 239000012530 fluid Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims description 39
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 36
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 36
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 35
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 33
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 33
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 33
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 33
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 33
- 235000009569 green tea Nutrition 0.000 claims description 33
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 31
- 235000006533 astragalus Nutrition 0.000 claims description 27
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 25
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 25
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 25
- 241001506047 Tremella Species 0.000 claims description 25
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 23
- 241000018650 Pinus massoniana Species 0.000 claims description 23
- 235000011610 Pinus tabuliformis Nutrition 0.000 claims description 23
- 235000013399 edible fruits Nutrition 0.000 claims description 23
- 239000000654 additive Substances 0.000 claims description 20
- 244000241838 Lycium barbarum Species 0.000 claims description 19
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 19
- 235000015468 Lycium chinense Nutrition 0.000 claims description 18
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 17
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 17
- 241000790228 Nardostachys jatamansi Species 0.000 claims description 17
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 241001061264 Astragalus Species 0.000 claims description 14
- 229940107666 astragalus root Drugs 0.000 claims description 14
- 210000004233 talus Anatomy 0.000 claims description 14
- 235000002723 Dioscorea alata Nutrition 0.000 claims description 11
- 235000007056 Dioscorea composita Nutrition 0.000 claims description 11
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims description 11
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims description 11
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims description 11
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims description 11
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims description 11
- 241000606266 Nardostachys Species 0.000 claims description 11
- 235000004879 dioscorea Nutrition 0.000 claims description 11
- 241000908178 Tremella fuciformis Species 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 7
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims description 6
- 240000000249 Morus alba Species 0.000 claims description 6
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000011324 bead Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 240000005717 Dioscorea alata Species 0.000 claims 2
- 244000182216 Mimusops elengi Species 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 65
- 229940079593 drug Drugs 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000011538 cleaning material Substances 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 description 48
- 239000000047 product Substances 0.000 description 36
- 210000000952 spleen Anatomy 0.000 description 32
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 230000007812 deficiency Effects 0.000 description 19
- 238000011160 research Methods 0.000 description 18
- 239000000126 substance Substances 0.000 description 17
- 150000004676 glycans Chemical class 0.000 description 16
- 229920001282 polysaccharide Polymers 0.000 description 16
- 239000005017 polysaccharide Substances 0.000 description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 16
- 240000002624 Mespilus germanica Species 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 241000045403 Astragalus propinquus Species 0.000 description 14
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 14
- 229960001948 caffeine Drugs 0.000 description 14
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 14
- 229920002527 Glycogen Polymers 0.000 description 12
- 229930003935 flavonoid Natural products 0.000 description 12
- 150000002215 flavonoids Chemical class 0.000 description 12
- 235000017173 flavonoids Nutrition 0.000 description 12
- 229940096919 glycogen Drugs 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 230000000144 pharmacologic effect Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 244000281702 Dioscorea villosa Species 0.000 description 9
- 240000000950 Hippophae rhamnoides Species 0.000 description 9
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 240000004371 Panax ginseng Species 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 235000008434 ginseng Nutrition 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 229960003080 taurine Drugs 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 235000020510 functional beverage Nutrition 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 235000017709 saponins Nutrition 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 5
- 240000005250 Chrysanthemum indicum Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 241001521901 Tribulus lanuginosus Species 0.000 description 5
- 229930003270 Vitamin B Natural products 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 150000002989 phenols Chemical class 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000006651 lactation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000003859 lipid peroxidation Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N Calycosin Natural products C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 2
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 102000016878 Hypoxia-Inducible Factor 1 Human genes 0.000 description 2
- 108010028501 Hypoxia-Inducible Factor 1 Proteins 0.000 description 2
- 208000031814 IgA Vasculitis Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 235000019687 Lamb Nutrition 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 206010049565 Muscle fatigue Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 108091007960 PI3Ks Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 2
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 241000037831 Polygonatum sibiricum Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001165494 Rhodiola Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960004873 levomenthol Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- LZEPVVDVBJUKSG-UHFFFAOYSA-N pterocarpan Chemical compound C1=CC=C2C3COC4=CC=CC=C4C3OC2=C1 LZEPVVDVBJUKSG-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- -1 tyrosol glycoside Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-Hydroxyphenyl)ethanol Natural products OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000009346 Adenosine receptors Human genes 0.000 description 1
- 108050000203 Adenosine receptors Proteins 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241001117772 Elaeagnaceae Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000035756 Infantile asthma Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018651 Pinus tabuliformis Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 241000159213 Zygophyllaceae Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003935 attention Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000376 effect on fatigue Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- 101150046266 foxo gene Proteins 0.000 description 1
- 229940076988 freshmint Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical compound C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- 235000002324 isoflavanes Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 125000001474 phenylpropanoid group Chemical group 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000010535 positive regulation of brown fat cell differentiation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-fatigue health product and a preparation method thereof, wherein the anti-fatigue health product comprises the following raw materials: the preparation method of the anti-fatigue health-care product comprises the following steps of: selecting and cleaning materials, pretreating the raw materials, decocting the raw materials for the first time, filtering to obtain a first liquid medicine, decocting for 1-2 times, mixing the liquid medicines, decocting, filtering, concentrating to obtain a fluid extract, adding proper maltose or honey, and decocting to obtain a finished product. The anti-fatigue health product and the preparation method thereof are prepared based on the guidance of the theory of traditional Chinese medicine, the main components are selected from medicinal and edible medicinal materials, the anti-fatigue health product has no toxic or side effect, is wide in applicable population, quick in effect, good in effect, simple to prepare, has good treatment and relief effects on fatigue caused by various factors, has the effects of strengthening the body resistance and consolidating the constitution, and is mild in medicine property and suitable for long-term administration.
Description
Technical Field
The invention relates to the technical field of anti-fatigue health care products, in particular to an anti-fatigue health care product and a preparation method thereof.
Background
The fatigue in a broad sense includes physical fatigue, mental fatigue, psychological fatigue and mixed type fatigue. Traditional Chinese medicine has related records about fatigue in ancient books such as Huangdi's classic and plain questions, plain questions and pain-relieving treatises, and Jinkui jade function, the slightly edited and revised treatises, wherein fatigue is mainly attributed to liver function dominance and fatigue loss of primordial qi. The mechanism of fatigue generation is quite complex, and recent modern related researches suggest that the causes of fatigue are mainly attributed to the following three factors: 1. consumption of energy materials; 2. a large accumulation of metabolites; 3. changes in the environment in and out of the body, endocrine disorders, blood glucose lowering, ATP reduction, etc., which cause failure of the impulse of the central nervous system to generate or maintain the impulse to the muscles enough to meet the exercise needs, are the main causes of muscle fatigue during work.
The results of the World Health Organization (WHO) survey show that the global population is only 5% healthy, 20% sick, and 75% of the vast majority of the population is sub-healthy between healthy and sick. According to survey, the subhealth population in China accounts for about 60-70% of the total population. Through related researches, fatigue is one of the most common symptoms in sub-health, accounts for more than 40% of sub-health people, and is one of the causes most influencing the life quality of the sub-health people. According to the investigation of the world health organization, more than 35% of people worldwide are in fatigue state, especially 60% -75% of middle-aged male people in fatigue state. Along with social development, fatigue has become an increasingly non-negligible problem commonly possessed by modern people, and related medical researches show that long-term fatigue can cause feelings of boredom and conflict of people for work and study, interpersonal relation disorder and simultaneous accompanying multiple systemic symptoms, such as headache, dizziness, pharyngalgia, muscle and joint pain, anorexia, nausea, night sweat and the like, and the symptoms of difficult falling asleep, frequent waking in sleep, daytime sleepiness and the like are frequently presented. Along with the concern of people on fatigue, huge anti-fatigue health care products are in need of oil.
At present, the anti-fatigue health care products on the market are roughly divided into three types, wherein the two types are mainly used.
The first category is various functional beverages, and the main function of the functional beverages is sports fatigue resistance. In 1982, the definition of exercise-induced fatigue was unified in the fifth international exercise biochemical conference, and the exercise-induced fatigue was considered as follows: "the physiological process of the body cannot continue its function at a certain level or and the organs cannot maintain a predetermined exercise intensity.
Taking a functional beverage as an example, the formula composition of the functional beverage taking a can as a unit is as follows:
125mg of taurine, 50mg of lysine, 50mg of caffeine, 50mg of inositol, 61 mg of vitamin B, 123-123 ug of vitamin B and 10mg of nicotinamide.
125mg of taurine, 50mg of lysine, 50mg of inositol, 50mg of caffeine, 10mg of vitamin PP, 61 mg of vitamin B and 123 ug of vitamin B.
The two formulas are summarized to obtain the formula; the common components of the two are taurine, lysine, caffeine and vitamin. The function of resisting sports fatigue is mainly realized through the following mechanisms;
1. taurine
Taurine is essential amino acid for human body condition, has the main biological effects of maintaining the stability of membrane structure and regulating osmotic balance, has the function of preventing lipid peroxidation of cell membrane, and is an important cell protective agent. The most closely related expression of increased free radical production during exercise and reduced exercise capacity is that free radicals cause lipid peroxidation in biological membranes of various organs in vivo. Taurine as sports nutritional supplement can directly exert its effectThe antioxidant function can also enhance the antioxidant capacity of the organism by improving the activity of an antioxidant enzyme system in vivo, protect cell membranes from being attacked by free radicals and further enhance the movement capacity of the organism. Taurine can effectively regulate Ca caused by various reasons2+Dyshomeostasis, a good endogenous Ca2+A stabilizing regulator. Lipid peroxidation and Ca occurring in exercise-induced fatigue2+There is a close relationship between homeostatic disorders, disorders of energy metabolism and biofilm damage, and taurine has a good effect on all of these processes.
2. Caffeine
Caffeine acts on adenosine receptors to delay fatigue, which may be manifested in particular by increased lipolysis of caffeine, reduced glycogen to delay fatigue, by regulation of Ca2+Concentration increases muscle contractile potency, delays fatigue by reducing the perception of effort. Meanwhile, caffeine can promote adrenalin in blood to be obviously increased, so that the heart rate is accelerated, the blood flow is increased, the oxygen delivery capacity is improved, tricarboxylic acid circulation is promoted to be smoothly carried out, and energy is ensured to be continuously supplemented.
3. Vitamin preparation
Because vitamins participate in various metabolisms of organisms, and deficiency and insufficiency of the vitamins can generate adverse effects on the movement ability, the work output can be reduced, and exercise fatigue and the like are easy to occur. Comprehensive supplementation is better than single supplementation.
4. Candy
Is the main energy source substance of muscles during exercise, and the sources in the body are blood sugar, muscle glycogen and liver glycogen. During long-time exercise, energy supply and blood sugar concentration in the body are mainly maintained by the hydrolysis of muscle glycogen and liver glycogen. Before exercise, the intake of carbohydrate in vivo is increased, so that sugar intake and utilization of muscle can be increased, and hepatic glycogen decomposition can be reduced, thereby saving muscle glycogen and hepatic glycogen, improving exercise ability, delaying fatigue, and preventing sports injury.
The sugar of the sports drink is preferably compounded by a plurality of sugar sources of glucose, sucrose and oligosaccharide. Besides relieving insulin reaction, the preparation can also adjust osmotic pressure, improve flavor, stimulate various sugar absorption ways of human body, and promote the absorption and utilization of sugar and water.
5. Electrolyte
The function of the ionic metabolism in the exercise-induced fatigue is more and more emphasized by people, and the exercise-induced skeletal muscle fatigue can be caused by the disturbance of the ionic metabolism during exercise.
However, studies show that although caffeine can improve alertness, sensitivity and attention of people, caffeine can cause caffeine poisoning after long-term taking in a large amount, symptoms of caffeine are similar to anxiety, and caffeine can have certain negative effects on osteoporosis or hip fracture, and particularly, the caffeine can cause bone loss of people with low calcium intake. Taking functional beverages in large quantities for a long time may lead to addiction and even some mental disorders. Meanwhile, elements such as sodium in the functional beverage can increase the burden of the organism, and cause negative effects such as increased heart load, increased blood pressure and the like. Therefore, such functional beverages are not suitable for people with hypertension and heart disease.
The second type of anti-fatigue health care product mainly comprises anti-fatigue plant active ingredients which are researched more in the prior art. The following plants are mainly included:
1. ginseng radix
Ginseng (Panax ginseng C.A. Meyer) is a perennial herb of Panax of Araliaceae. Modern pharmacological research finds that ginseng contains various chemical components, mainly including ginsenoside, ginseng polysaccharide, polypeptide, fatty acid, amino acid, polyacetylene alcohol and the like. In recent years, multi-center animal and clinical experimental research at home and abroad prove that ginseng has the anti-fatigue effect, the basis of the anti-fatigue substance of ginseng is considered to be mainly ginsenoside, and related researches on the anti-fatigue effect mechanism of ginsenoside are performed from a plurality of angles of resisting free radicals, regulating carbohydrate metabolism, reducing lactic acid accumulation, resisting central neurotransmitter disorder and the like.
2. Rhizome of Siberian solomonseal
Rhizoma Polygonati (Polygonatum sibiricum) is rhizome of Polygonatum sibiricum of Polygonatum of Liliaceae, and has effects of invigorating spleen, moistening lung, and promoting fluid production. The rhizome contains polysaccharide, flavone, and microelements such as Fe, Mn, Cu, Zn, Ca, Mg, etc., wherein the rhizoma Polygonati polysaccharide has various biological functions and biological activities, and has effects in resisting bacteria, resisting oxidation, and relieving fatigue.
3. Rhodiola root
The radix Rhodiolae is perennial herb or shrub of Rhodiola L, and contains salidroside and tyrosol glycoside as main active ingredients, and phenols, flavonoids, coumarins, organic acids, and trace elements. A large number of researches show that the rhodiola rosea has the effects of reducing oxygen consumption rate, increasing exercise endurance, enhancing glycogen storage, improving aerobic metabolic processes of important organs such as heart and brain, obviously improving the content of glycogen in liver and cardiac muscle and improving the level of sodium element in heart and lung tissues of animals, thereby relieving organ damage caused by hypoxia.
4. Sea-buckthorn
Hippophae rhamnoides (Hippophae rhamnoides L.) is deciduous shrub or small tree of Hippophae of Elaeagnaceae (Hippophae rhamnoides L.), and is also called Hippophae Rhamnoides or Hippophae rhamnoides (Hippophae rhamnoides L.). Sea-buckthorn is one of the plants both as medicine and food, which is issued by Ministry of health in 1988, and contains a plurality of physiological active substances, wherein 14 vitamins, 12 organic acids and monosaccharides, 22 amino acids and amides, 7 fatty acids, 32 lipids, 30 phenols and flavonoids, 4 proteins and 29 trace elements are detected.
Research shows that the sea buckthorn has good functions of hypoxia tolerance, myocardial oxygen consumption reduction, oxidation resistance and the like, and also has the effects of immunity enhancement, auxiliary blood fat reduction and the like.
5. Tribulus terrestris
The Chinese pharmacopoeia records that the dried mature fruits of tribulus terrestris (Tribu-lus terrestris L.) belonging to family Zygophyllaceae are named as tribulus terrestris, tribulus terrestris and tribulus terrestris, and have the effects of calming liver, resolving stagnation, promoting blood circulation, dispelling wind, improving eyesight and relieving itching. Can be used for treating headache, vertigo, distending pain in chest and hypochondrium, milk retention, mammary abscess, conjunctival congestion, nebula, rubella and pruritus. Mainly contains saponins, flavonoids, alkaloids, polysaccharides, and other compounds, and also contains sterols, amino acids, terpenes, fatty acids, and inorganic salts.
The fructus Tribuli extract can prolong the time from running the platform to exhaustion of the rat, and has antifatigue effect; its antifatigue effect may be related to its increase in glycogen content, elevation of blood testosterone levels.
The health care product mainly develops active ingredients in traditional medicinal plants by means of modern technological development, clarifies the action mechanism of the active ingredients in a human body and achieves the anti-fatigue health care effect, but the health care product has the following problems. One is that the active substances are mostly extracted from natural plants at present, and traditional rare traditional Chinese medicines such as ginseng and rhizoma polygonati have a series of risks such as lack of wild resources, limited artificial planting yield and heavy metal pollution caused by pesticide residues. And secondly, the health-care products need a certain taking period to have a more obvious improvement effect. And thirdly, the medicine has more and single action components and is suitable for people or has limited effect.
And thirdly, the traditional Chinese medicine formula obtained through reasonable compatibility under the guidance of the traditional Chinese medicine theory is applied to the anti-fatigue health care product.
The traditional Chinese medicine considers that the main pathogenesis of fatigue type sub-health is spleen deficiency and liver depression with heart deficiency, the spleen governs muscles and limbs, and the spleen deficiency causes physical fatigue and weakness; the liver regulates qi movement and is good at mind, and depression of the liver tends to cause dysphoria or depression; heart governing mind is the major part of the five zang-organs and six fu-organs, and heart deficiency leads to dizziness, confusion of thinking and poor memory. Therefore, the main treatment policy of the traditional Chinese medicine in the treatment of fatigue is to soothe the liver, relieve depression, invigorate the spleen and replenish qi. However, because of the influence of actual environment and conditions, the traditional medicine is not found in the field of anti-fatigue health care products and medicines for building a large tree.
According to the theory of traditional Chinese medicine, the pathogenesis of chronic fatigue syndrome is caused by imbalance of yin and yang of the organism, imbalance of qi and blood, and imbalance of visceral functions due to factors such as congenital deficiency, loss of work and rest, abnormal daily life, improper diet, emotional and emotional disorders, non-tranquility of the living place, and senile and body weakness. The common symptoms comprise liver qi stagnation syndrome, liver depression and spleen deficiency syndrome, heart and spleen deficiency syndrome, liver and kidney yin deficiency syndrome, lung and spleen qi deficiency syndrome, spleen deficiency and dampness obstruction syndrome, liver depression and fire transformation syndrome, and phlegm heat internal disturbance syndrome, and the main disease is in liver, spleen and kidney.
The common clinical manifestations can be divided into the following categories
The physical symptoms such as fatigue, sleep disorder, pain and the like are mainly expressed;
secondly, the mental and psychological symptoms such as depression, fright, uneasiness, irritability, fear, timidity, short-term memory decline, attention failure to concentrate and the like are mainly expressed;
the social adaptability reduction such as reduction of interpersonal interaction frequency or tension of interpersonal relationship is taken as the main point;
at present, western medicines are not considered to be chemical components or medicines capable of effectively treating CFS, only can relieve partial symptoms and improve functional state, and a plurality of medicines have adverse reactions.
The traditional Chinese medicine adopts the traditional Chinese medicine to treat chronic fatigue syndrome by internal treatment, and a plurality of documents show that the traditional Chinese medicine has good effect; .
Disclosure of Invention
The invention aims to provide an anti-fatigue health-care product and a preparation method thereof, and aims to solve the problems that the existing anti-fatigue health-care product proposed by the background art can cause adverse reactions of a human body, neglects psychological fatigue and mental fatigue, takes effect slowly and has complex preparation conditions when being taken by the human body for a long time.
In order to achieve the purpose, the invention provides the following technical scheme: an anti-fatigue health product, which comprises the following raw materials: malt, Chinese date, astragalus, medlar, yam, mint, green tea and additives.
Preferably, the additives are Chinese pine node and nardostachys root.
Preferably, the additives are chrysanthemum and tremella.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-10 parts of Chinese pine nodular branch and 1-5 parts of nardostachys root.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-5 parts of chrysanthemum and 0.1-5 parts of tremella.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 5-10 parts of Chinese pine node and 2-4 parts of nardostachys root.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 6 parts of Chinese pine node and 2.4 parts of nardostachys root.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 1-4 parts of chrysanthemum and 0.1-3 parts of tremella.
Preferably, the anti-fatigue health care product consists of the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 2 parts of chrysanthemum and 0.6 part of tremella.
The invention provides another technical scheme for providing a preparation method of an anti-fatigue health-care product, which comprises the following steps:
the method comprises the following steps: when chrysanthemum and tremella are selected as additives for preparation, high-quality malt, Chinese date, astragalus, medlar, yam, tremella and chrysanthemum are selected, washed first and added with clear water with the dry weight of 8-12 times, and then placed in an extraction container for soaking for 12 hours in advance. Cleaning the superior mint and green tea, adding clear water with the weight 4-6 times of the dry weight, taking another container, and putting the container into the container for soaking for 2 hours in advance;
step two: decocting fructus Hordei Germinatus for 1.5 hr, adding soaked herba Menthae and green tea, decocting for 0.5 hr, filtering to obtain first medicinal liquid, adding the residue into the first-extracted clear water, decocting for 2-3 hr for 1-2 times, mixing the medicinal liquids, and filtering;
step three: concentrating the above medicinal liquid under boiling state to obtain fluid extract;
step four: adding maltose 2-3 times or Mel 1-2 times of the fluid extract, stirring to obtain paste, and pulling flag or dripping water to form bead;
step five: the judgment standard of the third step is that no water mark exists on the upper edge of mulberry paper or herbal paper medicine liquid which is dropped on the mulberry paper or herbal paper;
step six: when the Chinese pine nuts and the nardostachys chinensis batal are selected as the additives for preparation, the tremella fuciformis obtained in the first step to the fourth step is replaced by the Chinese pine nuts, and the chrysanthemum is replaced by the nardostachys chinensis batal.
Compared with the prior art, the invention has the beneficial effects that: the anti-fatigue health product and the preparation method thereof are prepared based on the guidance of the theory of traditional Chinese medicine, have the advantages that the main components are selected from medicinal and edible medicinal materials without toxic or side effect, the application crowd is wide, the effect is quick and good, the preparation is simple and the like, the effect of tonifying spleen and qi has good treatment and relief effect on fatigue caused by various factors, and the anti-fatigue health product has the effect of strengthening body resistance and consolidating the foundation, and is mild in medicine property and suitable for long-term administration;
the prescription selects the nardostachys chinensis batal and the Chinese pinecone, and the nardostachys chinensis batal, the malt and the Chinese date in the prescription have the functions of tonifying spleen and nourishing blood and are combined with the astragalus root to play the roles of tonifying qi and nourishing blood; the four medicines of the nardostachys chinensis bunge, the mint, the malt and the green tea are used together to play the effects of activating spleen and nourishing spirit, and soothing liver and relieving depression; the combination of the Chinese medicinal herbs of the Chinese pine knot, the Chinese date, the medlar and the Chinese yam has the effects of nourishing the acquired constitution and supplementing the innate constitution; the functions of tonifying, non-diarrhea, qi-blood nourishing and spleen-stomach coordination are combined above to achieve the effects of benefiting qi, nourishing blood, removing blood stasis and resisting diseases, and if tremella and chrysanthemum are adopted, the effects of tonifying spleen and nourishing blood of malt and Chinese date and the astragalus root are combined together to achieve the effects of benefiting qi and nourishing blood; the chrysanthemum, the mint, the malt and the green tea are used together to play the roles of activating spleen and nourishing spirit, and soothing liver and relieving depression; the combination of the four medicines of the tremella, the Chinese date, the medlar and the yam has the effects of nourishing the acquired foundation and supplementing the innate foundation;
1. the scheme adopts the mint, the mint oil is the main chemical component in the mint, the fresh mint leaves contain 0.8-1% of volatile oil, the dry stem leaves contain 1.3-2% of volatile oil, phenolic compounds, amino acids, various trace elements and other non-volatile components, the main component in the mint volatile oil is levomenthol (Mentho1) with the content of 62-87%, and more than 60 sesquiterpene volatile components such as levomenthol, isomenthone, pulegone and the like are also contained, and the small amount of mint oil can stimulate central nerves of a human body through oral administration, expand capillary vessels of the skin, promote secretion of sweat glands, increase heat dissipation, have the effects of sweating and fever reduction, and simultaneously can resist early pregnancy, implantation, inhibit uterine contraction, resist fungi and resist viruses; the non-volatile components have liver protecting, gallbladder promoting, anti-tumor, hair blackening, and antioxidant effects;
meanwhile, the mint is the dry overground part of mint (Mentha haplocalyx Briq.) of a Labiatae plant, is pungent in taste, cool in nature, enters lung and liver channels, disperses wind and heat, clears head and eyes, relieves sore throat, promotes eruption, soothes liver and promotes qi circulation, and is a traditional medicine and food dual-purpose plant;
2. the scheme adopts Chinese dates which have more complex components, and chemical components such as triterpenes, saponins, alkaloids, flavonoids, glycosides, nucleosides, saccharides, proteins, amino acids, vitamins, amides, organic acids, steroids and the like are separated from the Chinese dates in sequence until today, the Chinese dates also have multiple pharmacological activities and health-care effects, mainly have the effects of increasing cAMP in leucocytes, resisting allergic reaction, inhibiting nerves, protecting livers, enhancing muscle strength, resisting cancers, resisting mutation, resisting lipid peroxidation and the like, and are clinically used for treating diseases such as allergic purpura, non-thrombocytopenic purpura, hemorrhoidal bleeding, chronic atrophic gastritis, ulcer, diarrhea, infantile asthma, skin cancer and the like;
meanwhile, the Chinese date is a dry mature fruit of a Rhamnaceae plant Chinese date (Ziziphus jujuba Mill.), the fruit is harvested, dried, sweet and warm in autumn when ripe, enters spleen, stomach and heart channels, supplements middle warmer and benefits qi, nourishes blood and tranquilizes, and is used for spleen deficiency and poor appetite, debilitation and loose stool, women's hysteria, Chinese date germplasm resources are very rich and account for more than 98% of the total amount of the world, and the Chinese date is a traditional medicine-food homologous variety and contains abundant saccharide substances such as polysaccharide, cellulose and fructose, organic acid and ester substances thereof, saponin substances, flavonoid substances, vitamins, proteins, amino acids, mineral elements and other chemical components;
3. the scheme adopts nardostachys chinensis which contains terpenoids, flavonoids, coumarins, lignans and volatile oil, and also contains saccharides, inorganic elements and other chemical components, and has the effects of clearing heat, detoxifying and diminishing inflammation, and meanwhile, the nardostachys chinensis has the effects of resisting epilepsy, convulsion, depression, malaria, bacteria, inflammation, arrhythmia, oxidation, anxiety, blood sugar metabolism and the like;
meanwhile, the Nardostachys chinensis (L.) Merr is a dry root and rhizome of Nardostachys chinensis (Nardostachys jatamansi DC) of Valerianaceae, is pungent and sweet in taste, warm in nature, and capable of entering spleen and stomach channels, regulating qi to alleviate pain, relieving depression and activating spleen, externally used for eliminating dampness and reducing swelling, and researches on chemical components of the Nardostachys chinensis (L.) Merr have been reported at present, wherein the Nardostachys chinensis (L.) Merr comprises polysaccharides, organic acids, flavonoids, phenylpropanoids, terpenes, volatile oil and the like, and the main components are terpenes and volatile oil, so that the Nardostachys chinensis (L.) Merr has pharmacological effects of resisting depression and;
4. the scheme adopts the medlar which is a Chinese herbal medicine with sweet nature, and the pharmacological effects of the medlar are tonifying kidney and nourishing yin, treating consumptive disease and quenching thirst;
meanwhile, the medlar is a dry mature fruit of Ningxia medlar (Lycium barbarum L) of Solanaceae, is a traditional medicine-food dual-purpose tonifying traditional Chinese medicine, has mild nature and sweet taste, belongs to liver and kidney channels, has the effects of nourishing liver and kidney, replenishing vital essence and improving eyesight, and modern research shows that the medlar contains rich medlar polysaccharide, betaine, medlar pigment and other substances, wherein the medlar polysaccharide has the effects of enhancing the immunity of human bodies and animals, resisting aging, preventing tumors, resisting fatigue, preventing radiation, protecting and nourishing the liver and the like, and the medlar pigment has an important effect on resisting oxidation;
5. the scheme adopts astragalus membranaceus, 11 active ingredients in the astragalus membranaceus comprise 6 flavonoid ingredients including calycosin glucoside, calycosin, formononetin, isoflavan and pterocarpan, saponin ingredients of astragalus membranaceus, including saponin ingredients of astragalus membranaceus I, II, III and IV4 and cane sugar, the astragalus membranaceus mainly relates to biological processes of nitric oxide biosynthesis, hydrogen peroxide reaction, positive regulation of brown fat cell differentiation, active oxygen metabolism and the like, and the anti-fatigue effect is achieved by regulating cancer channels, FoxO, phosphatidylinositol 3-kinase (PI3K) -protein kinase B (Akt), hypoxia inducible factor-1 (HIF-1), Vascular Endothelial Growth Factor (VEGF), Mitogen Activated Protein Kinase (MAPK), Ca2+ signal channels, oxidative stress reaction and the like;
meanwhile, the Astragalus membranaceus is the dried root of leguminous plant Astragalus mongholicus (Fisch.) membranaceus (Bge.) Bge. Hsiao or Astragalus membranaceus (Fisch.) membranaceus (Bge.) Bge. spring and autumn, fibrous root and root head are removed, and the Astragalus membranaceus is dried, sweet and slightly warm and enters lung and spleen channels, and is listed as the superior product by Shen nong Bencao Jing as the traditional Chinese medicine and food tonifying medicine, the Astragalus membranaceus is considered as a good qi tonifying medicine in the traditional Chinese medical science, the Astragalus membranaceus is called as 'ten medicines eight Astragalus membranaceus', the Astragalus membranaceus has the effects of tonifying qi and raising yang, consolidating exterior and arresting sweating, inducing diuresis and reducing edema, nourishing blood, promoting the circulation of qi and dredging arthralgia and the like, is commonly used for loose stool, sinking of qi, deficiency and spontaneous sweating, edema due to deficiency, internal heat and thirst quenching and the like, and the main components of the Astragalus membranaceus comprise flavonoids, saccharides, organic acids, amino acids, the research on the anti-fatigue, the anti-inflammatory literature shows that the modern pharmacology research has the pharmacological effect, the astragaloside obviously improves the Peroxidase (POD) level, the total antioxidant capacity (T-AOC) and the activity of Ca2+ -Mg2+ -ATP enzyme of skeletal muscle of a rat with sports fatigue, reduces the content of Lactate Dehydrogenase (LDH), has the function of protecting muscle tissue of the rat with sports fatigue, the flavonoid component in the astragalus and fingerprint chromatogram peaks of other components (containing saponins) have the function of enhancing anti-fatigue effect, the astragalus polysaccharide can prolong the negative gravity exhaustion swimming time of the mouse, reduce the accumulation of blood lactic acid of the organism, increase the storage of liver glycogen, play the roles of delaying fatigue generation/improving the sports ability, improve the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in liver tissue of the mouse, have the function of resisting oxidative damage, and can protect oxidative stress induced by sports
6. The chrysanthemum is adopted in the scheme, the effective components in the chrysanthemum comprise volatile oil, amino acid, flavonoid, trace vitamin B and the like, pharmacological research shows that the chrysanthemum has the function of resisting pathogens, has a certain inhibition effect on gram-positive bacteria and human tubercle bacillus in vitro, and can also enhance the resistance of capillary vessels, inhibit the permeability of the capillary vessels and have the anti-inflammatory effect;
meanwhile, Chrysanthemum is a dry head-shaped inflorescence of Chrysanthemum (Chrysanthemum morifolium Ramat) of the Compositae, medicinal materials are divided into Chrysanthemum morifolium, Chrysanthemum morifolium and Chrysanthemum indicum according to different production places and processing methods, and the Chrysanthemum morifolium, Chrysanthemum indicum, Chrysanthemum morifolium, Chrysanthemum: ju can promote the five vessels, regulate the four limbs, treat head wind heat; is a medicine and food dual-purpose variety; modern pharmacological studies show that: the chrysanthemum is rich in volatile oil and flavonoid, and also contains various physiological active substances such as chlorogenic acid, polysaccharide, phenols, fatty acid, trace elements and the like, and related experiments show that the chrysanthemum extract has the effects of resisting fatigue and aging;
7. the scheme adopts the green tea, the green tea extract is the most effective substance for resisting the fatigue of the anaerobic exercise, the green tea extract can effectively relieve the fatigue state of the body of the athlete after the anaerobic exercise, and simultaneously can quickly recover the body of the athlete to the normal state, thereby ensuring good exercise performance and the body health of the athlete, and meanwhile, the substance is nontoxic and free of stimulant components, and can control the serum level, slow down the metabolism of free radicals, protect skeletal muscles, protect kidney and the like;
meanwhile, the green tea is one of the main tea types in China, is one of the traditional medicine and food homologous varieties, contains tea polyphenol, catechin, chlorophyll, caffeine, amino acid, vitamins and other nutritional ingredients, and numerous researches show that the green tea has multiple effects of regulating glycolipid metabolism, improving cardiovascular diseases, resisting cancer, resisting oxidation and the like, and meanwhile, modern pharmacological researches also prove that the green tea has good fatigue resistance and effectively relieves the fatigue state of the human body after anaerobic exercise, and simultaneously helps to quickly recover the body to a normal state, the tea polyphenol is a main ingredient for determining the color, the fragrance, the taste and the effect of the tea and accounts for 20-30% of the dry weight of the tea, and related researches show that the tea polyphenol has good anti-exercise fatigue effect;
8. the malt adopted in the scheme has sweet taste and mild nature, and has the functions of invigorating qi, promoting digestion, strengthening spleen, stimulating appetite, removing milk and relieving flatulence, and is used for treating indigestion, abdominal distension and pain, spleen deficiency and anorexia, milk stasis, breast gall, women's lactation cessation, raw malt, spleen strengthening, stomach harmonizing and lactation promotion, and spleen deficiency and anorexia and milk stasis; parched fructus Hordei Germinatus has effects of activating qi-flowing, resolving food stagnation, and promoting lactation, and can be used for treating indigestion and lactation interruption of women; the scorched malt is used for promoting digestion and resolving stagnation, is used for treating indigestion and abdominal distending pain, and is a common digestion-promoting medicine in clinical traditional Chinese medicine;
meanwhile, the malt is a processing product obtained by germinating and drying mature fruits of gramineous plant barley (Hordeurn vulgare L.), is sweet, neutral, enters spleen and stomach channels, has the effects of promoting qi circulation to promote digestion, strengthening spleen to stimulate appetite and the like, is one of medicinal and edible varieties published by Weijian, and is recorded in the Chinese pharmacopoeia 2015 edition: the raw malt has the effects of strengthening spleen and stomach, soothing liver and promoting qi circulation, is used for treating spleen deficiency and anorexia and liver depression and qi stagnation, and is a wonderful product for soothing liver and relieving depression;
9. the scheme adopts Chinese yam, particularly Tiegun Chinese yam, which is rich in polysaccharide and is an important active substance, wherein the Chinese yam polysaccharide is a main active component in the Chinese yam, mainly comprises mannose, xylose, arabinose, glucose and galactose, and has rich pharmacological activity;
meanwhile, the yam is a dry rhizome of Dioscorea opposita (Dioscorea opposita L.) belonging to the family Dioscoreaceae, is a traditional medicine and food dual-purpose plant, has the advantages of mild nature and sweet taste, and has the effects of invigorating spleen, lung and kidney channels, tonifying spleen and nourishing stomach, promoting the production of body fluid and benefiting lung, and tonifying kidney essence, and is used for treating spleen deficiency and poor appetite, chronic diarrhea, lung deficiency and cough, kidney deficiency and spermatorrhea, leukorrhagia, frequent micturition, asthenic fever and diabetes, and the yam contains starch, fat, protein and various mineral nutritive elements as well as various components such as zaixe, phenols, polysaccharides and the like according to the reports at home and abroad, and related experiments show that the yam can play a good anti-fatigue effect when being directly taken as a food, and also play a certain role in recovering sports fatigue, and related pharmacological researches prove that the yam polysaccharide has a good anti-fatigue and anti;
10. according to the scheme, tremella is adopted, is an edible fungus, has the effects of tonifying spleen, stimulating appetite, nourishing yin, moistening lung and the like, and has wide pharmacological effects such as immunoregulation, tumor resistance, oxidation resistance, blood sugar and blood fat reduction and the like as tremella polysaccharide is taken as one of main active ingredients;
meanwhile, the Tremella fuciformis is Tremella fuciformis Berk (TF), also called as Tremella fuciformis and Tremella fuciformis, belongs to the Tremella family of basidiomycetes, is a tonic for treating weakness and aging, enters the lung, stomach and kidney meridians, has the effects of nourishing yin and tonifying lung, nourishing stomach and promoting the secretion of saliva or body fluid, tonifying kidney and replenishing vital essence and calming mind, is used as a traditional edible fungus and is named as 'crown in fungus', is regarded as a famous and precious tonic good product which is a palace life prolonging tribute during clearing, contains protein, fat and 17 amino acids and mineral substances, and researches on the Tremella fuciformis prove that the Tremella fuciformis polysaccharide has various effects of oxidation resistance, tumor resistance, immunoregulation, blood sugar and fat reduction, radiation resistance, virus resistance and the like;
11. in the scheme, the Chinese pine node is adopted, the volatile oil in the Chinese pine node has special fragrance, and the Chinese pine node is favorable for activating blood and relieving pain and is favorable for resisting fatigue;
meanwhile, the Chinese pine node is a dry nodular node or a branch node of Pinus tabulaeformis (Pinus tabulieformis Carr.) or Pinus massoniana lamb (Pinus assassiana lamb.) belonging to Pinaceae, can be harvested all the year round, is sawed and dried in the shade, is bitter and pungent in taste, warm in nature, enters liver and kidney meridians, and has the effects of dispelling wind and removing dampness, and dredging collaterals and relieving pain.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that: an anti-fatigue health product, which comprises the following raw materials: malt, Chinese date, astragalus, medlar, yam, mint, green tea and additives.
In the invention, the addition materials are Chinese pine node and nardostachys root.
In the invention, the additives are chrysanthemum and tremella.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-10 parts of Chinese pine nodular branch and 1-5 parts of nardostachys root.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-5 parts of chrysanthemum and 0.1-5 parts of tremella.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 5-10 parts of Chinese pine node and 2-4 parts of nardostachys root.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 6 parts of Chinese pine node and 2.4 parts of nardostachys root.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 1-4 parts of chrysanthemum and 0.1-3 parts of tremella.
The invention further discloses an anti-fatigue health-care product which is prepared from the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 2 parts of chrysanthemum and 0.6 part of tremella.
The invention provides another technical scheme for providing a preparation method of an anti-fatigue health-care product, which comprises the following steps:
the method comprises the following steps: when chrysanthemum and tremella are selected as additives for preparation, high-quality malt, Chinese date, astragalus, medlar, yam, tremella and chrysanthemum are selected, washed first and added with clear water with the dry weight of 8-12 times, and then placed in an extraction container for soaking for 12 hours in advance. Cleaning the superior mint and green tea, adding clear water with the weight 4-6 times of the dry weight, taking another container, and putting the container into the container for soaking for 2 hours in advance;
step two: decocting fructus Hordei Germinatus for 1.5 hr, adding soaked herba Menthae and green tea, decocting for 0.5 hr, filtering to obtain first medicinal liquid, adding the residue into the first-extracted clear water, decocting for 2-3 hr for 1-2 times, mixing the medicinal liquids, and filtering;
step three: concentrating the above medicinal liquid under boiling state to obtain fluid extract;
step four: adding maltose 2-3 times or Mel 1-2 times of the fluid extract, stirring to obtain paste, and pulling flag or dripping water to form bead;
step five: the judgment standard of the third step is that no water mark exists on the upper edge of mulberry paper or herbal paper medicine liquid which is dropped on the mulberry paper or herbal paper;
step six: when the Chinese pine nuts and the nardostachys chinensis batal are selected as the additives for preparation, the tremella fuciformis obtained in the first step to the fourth step is replaced by the Chinese pine nuts, and the chrysanthemum is replaced by the nardostachys chinensis batal.
The formula can be prepared into different dosage forms, such as oral liquid, tablets, capsules, paste, granules, pills, powder, solution and the like, and the different dosage forms can be used as a health-care product.
Example (b):
selecting 60 clinical subjects mainly suffering from fatigue, 40 male subjects, 20 female subjects, the maximum age of 45 years, the minimum age of 22 years, the average age of 33.2 years and the course of disease of 3 months to 1 year;
after excluding other diseases causing fatigue, reference is made to "sub-health clinical guidelines", which is divided into two groups of 30 persons each.
Two groups of subjects take oral liquid (prepared from rhizoma Nardostachyos, lignum Pini nodi/flos Chrysanthemi, and Tremella) prepared by decocting two groups of Chinese medicinal materials, 15g each time, and continuously taking with boiled water for 15 days. Evaluating the curative effect according to the following standard after the treatment course is finished;
and (3) curing: fatigue and other complications substantially disappear;
the curative effect is remarkable; fatigue and other complications partially disappear and the rest are effectively relieved;
the method is effective; fatigue and its complications are effectively relieved but not eliminated;
invalid; the symptoms are not obviously improved compared with the symptoms before the medicine taking;
the experimental results are as follows:
taking the following medicines: 20 patients are cured, the obvious curative effect is 6 patients, the effective is 4 patients, and no ineffective cases exist;
taking Tremella and flos Chrysanthemi; cure 18 people, have remarkable curative effect of 7 people, have 5 effective people and have no invalid case.
The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.
The above description is only for the specific embodiments of the present application, but the scope of the present application is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present application, and all the changes or substitutions should be covered by the scope of the present application. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.
Claims (10)
1. An anti-fatigue health product, which is characterized in that: the anti-fatigue health product comprises the following raw materials: malt, Chinese date, astragalus, medlar, yam, mint, green tea and additives.
2. The anti-fatigue health product according to claim 1, wherein: the additive is lignum Pini nodi and rhizoma Nardostachyos.
3. The anti-fatigue health product according to claim 1, wherein: the additives are chrysanthemum and tremella.
4. The anti-fatigue health product according to claim 2, wherein: the anti-fatigue health product comprises the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-10 parts of Chinese pine nodular branch and 1-5 parts of nardostachys root.
5. The anti-fatigue health product according to claim 3, wherein: the anti-fatigue health product comprises the following components in parts by weight: 1-20 parts of malt, 1-20 parts of Chinese date, 1-10 parts of astragalus root, 1-5 parts of wolfberry fruit, 1-5 parts of Chinese yam, 1-5 parts of mint, 1-5 parts of green tea and an additive consisting of 1-5 parts of chrysanthemum and 0.1-5 parts of tremella.
6. The anti-fatigue health product according to claim 4, wherein: the anti-fatigue health product comprises the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 5-10 parts of Chinese pine node and 2-4 parts of nardostachys root.
7. The anti-fatigue health product according to claim 6, wherein: the anti-fatigue health product comprises the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 6 parts of Chinese pine node and 2.4 parts of nardostachys root.
8. The anti-fatigue health product according to claim 5, wherein: the anti-fatigue health product comprises the following components in parts by weight: 10-20 parts of malt, 5-15 parts of Chinese date, 5-10 parts of astragalus, 2-4 parts of wolfberry fruit, 2-4 parts of Chinese yam, 2-4 parts of mint, 1-3 parts of green tea, 1-4 parts of chrysanthemum and 0.1-3 parts of tremella.
9. The anti-fatigue health product according to claim 8, wherein: the anti-fatigue health product comprises the following components in parts by weight: 18 parts of malt, 8 parts of Chinese date, 6 parts of astragalus root, 3 parts of wolfberry fruit, 2 parts of Chinese yam, 2 parts of mint, 1 part of green tea, 0.6 part of tremella and 2 parts of chrysanthemum.
10. A preparation method of an anti-fatigue health product is characterized by comprising the following steps: the preparation method of the anti-fatigue health product comprises the following steps:
the method comprises the following steps: when chrysanthemum and tremella are selected as additives for preparation, high-quality malt, Chinese date, astragalus, medlar, yam, tremella and chrysanthemum are selected for rush washing, and are put into an extraction container for soaking in advance for 12 hours by adding clear water with the dry weight of 8-12 times. Cleaning the superior mint and green tea, adding clear water with the weight 4-6 times of the dry weight, taking another container, and putting the container into the container for soaking for 2 hours in advance;
step two: decocting fructus Hordei Germinatus for 1.5 hr, adding soaked herba Menthae and green tea, decocting for 0.5 hr, filtering to obtain first medicinal liquid, adding the residue into the first-extracted clear water, decocting for 2-3 hr for 1-2 times, mixing the medicinal liquids, and filtering;
step three: concentrating the above medicinal liquid under boiling state to obtain fluid extract;
step four: adding maltose 2-3 times or Mel 1-2 times of the fluid extract, stirring to obtain paste, and pulling flag or dripping water to form bead;
step five: the judgment standard of the third step is that no water mark exists on the upper edge of mulberry paper or herbal paper medicine liquid which is dropped on the mulberry paper or herbal paper;
step six: when the Chinese pine nuts and the nardostachys chinensis batal are selected as the additives for preparation, the tremella fuciformis obtained in the first step to the fourth step is replaced by the Chinese pine nuts, and the chrysanthemum is replaced by the nardostachys chinensis batal.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011326832.4A CN112402569A (en) | 2020-11-24 | 2020-11-24 | Anti-fatigue health product and preparation method thereof |
CN202110269056.7A CN113018398A (en) | 2020-11-24 | 2021-03-12 | Anti-fatigue health product and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011326832.4A CN112402569A (en) | 2020-11-24 | 2020-11-24 | Anti-fatigue health product and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112402569A true CN112402569A (en) | 2021-02-26 |
Family
ID=74778504
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011326832.4A Pending CN112402569A (en) | 2020-11-24 | 2020-11-24 | Anti-fatigue health product and preparation method thereof |
CN202110269056.7A Pending CN113018398A (en) | 2020-11-24 | 2021-03-12 | Anti-fatigue health product and preparation method thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110269056.7A Pending CN113018398A (en) | 2020-11-24 | 2021-03-12 | Anti-fatigue health product and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN112402569A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112914000A (en) * | 2021-03-10 | 2021-06-08 | 西藏易达投资股份有限公司 | Pure natural plant extraction refined liquid beverage of Asiatic black fungus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1167144A (en) * | 1997-03-06 | 1997-12-10 | 苟根华 | Tonic health care wine and preparation method |
CN105412756A (en) * | 2015-12-28 | 2016-03-23 | 曹桂苟 | Traditional Chinese medicine formula for treatment of stomach cold |
CN107375538A (en) * | 2017-08-29 | 2017-11-24 | 成都三乙医疗科技有限公司 | A kind of green tea tea-drinking to refresh the mind |
-
2020
- 2020-11-24 CN CN202011326832.4A patent/CN112402569A/en active Pending
-
2021
- 2021-03-12 CN CN202110269056.7A patent/CN113018398A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112914000A (en) * | 2021-03-10 | 2021-06-08 | 西藏易达投资股份有限公司 | Pure natural plant extraction refined liquid beverage of Asiatic black fungus |
Also Published As
Publication number | Publication date |
---|---|
CN113018398A (en) | 2021-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
CN103689563A (en) | Health-preserving health food formula beneficial for improving sleep and preparation method thereof | |
CN105695258A (en) | Female health wine containing lychee seed saponin | |
CN101543248B (en) | A cold tea especially suitable for 'three high and one acid' population and method for preparing same | |
CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
CN107853517B (en) | Traditional Chinese medicine beverage capable of refreshing and resisting fatigue and preparation method thereof | |
CN106937741A (en) | A kind of degreasing linseed meal cancer-resisting health slimming method and preparation method thereof | |
CN102273679A (en) | Preparation method of beverage | |
CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
CN104223297B (en) | A kind of schisandra chinensis health-care oral liquid of slow down aging and preparation method thereof | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
CN112402569A (en) | Anti-fatigue health product and preparation method thereof | |
CN106109521A (en) | A kind of Radix Notoginseng oral liquid | |
CN103960415A (en) | Weight-losing health herbal tea and preparation method thereof | |
TW202330006A (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
CN108815015A (en) | A kind of eye mask and its production technology | |
CN108835615A (en) | A kind of composition for aided blood pressure-lowering | |
CN110960632B (en) | Formula of sleep improving product and preparation method thereof | |
CN107712890A (en) | A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof | |
CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
KR20160064057A (en) | Health supplement food containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
CN111418803A (en) | Preparation method of health preserving soup | |
CN105638961A (en) | Dark green tea composition with ramie leaves and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210226 |
|
WD01 | Invention patent application deemed withdrawn after publication |